<DOC>
	<DOCNO>NCT02813512</DOCNO>
	<brief_summary>The objective study confirm safety possible efficacy Adipose-Tissue Derived Stem Cells treatment chronic stroke . Specifically , study transplant autologous ADSCs brain surround ischemic infarct adult ( 65-80 year old ) subject chronic non-hemorrhagic stroke ( &gt; 6 month ) .</brief_summary>
	<brief_title>Clinical Trial Study About Human Adipose-Derived Stem Cells Stroke</brief_title>
	<detailed_description>This open-label clinical trial compare outcomes subject chronic stroke . Six subject treatment ( n=3 ) group . The treatment group receive brain transplant autologous ADSCs . Treatment group receive rehabilitation transplantation . Subjects assess magnetic resonance imaging ( MRI ) eight standardize stroke index : National Institutes Health Stroke Scale ( NIHSS ) , ( Barthel Index ) 、 ( Berg balance scale ) 、 ( Fugl - Meyer test ) 、 ( Action research arm test ) 、 ( Purdue pegboard ) 、 ( grip strength measurement ) 、 ( somatosensory evoke potential , SSEP ) 1 month , 3 month , 6 month treatment .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>stroke investigator age 65 80 year history stroke six month 10 year Systolic pressure Diastolic pressure maintain 160 mmHg 110 mmHg INR &lt; 2.5 , platelet count 1－5 x 10^5/μl Damaged area range 0.5 cm 6 cm brain MRI Pregnant woman Investigators AIDS , cancer , liver dysfunction Others ca n't fit trial evaluate investigator</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>